Boltz raises €25.2M Seed round
8 January 2026· London, United Kingdom· health, biotech, ai, b2b, pure_software
The funding will be used to launch the Boltz Lab platform, deploy AI-powered agents for small-molecule and protein design, integrate Pfizer's historical data into its foundation models, and expand the team following its formation as a public-benefit corporation.
Investors
LeadAmplify Partners
Also participating
Andreessen HorowitzObvious VenturesFactorial CapitalZetta Venture PartnersClement Delangue
About Boltz
Stage
Seed
Headquarters
London, United Kingdom
Founded
2024
Team Size
21–50
Sectors
healthbiotechaib2bpure_software